Your browser doesn't support javascript.
loading
Nonsustained ventricular tachycardia in heart failure with preserved ejection fraction.
Gutierrez, Alejandra; Ash, Jerry; Akdemir, Baris; Alexy, Tamas; Cogswell, Rebecca; Chen, Jane; Adabag, Selcuk.
Afiliación
  • Gutierrez A; Division of Cardiovascular Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
  • Ash J; Division of Cardiovascular Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
  • Akdemir B; Division of Cardiovascular Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
  • Alexy T; Division of Cardiovascular Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
  • Cogswell R; Division of Cardiovascular Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
  • Chen J; Division of Cardiovascular Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
  • Adabag S; Division of Cardiology, Minneapolis VA Health Care System, Minneapolis, Minnesota.
Pacing Clin Electrophysiol ; 43(10): 1126-1131, 2020 10.
Article en En | MEDLINE | ID: mdl-32809234
ABSTRACT

BACKGROUND:

Ventricular tachycardia (VT) is a common arrhythmia in heart failure with reduced ejection fraction but its incidence, predictors, and significance have not been determined in heart failure with preserved ejection fraction (HFpEF).

METHODS:

We performed a retrospective review of arrhythmias in two cohorts of patients with an HFpEF diagnosis. Patients in cohort 1 (n = 40) underwent routine arrhythmia surveillance with a 14-day ambulatory electrocardiogram (ECG) monitor. Patients in cohort 2 (n = 85) had cardiac pacemakers and underwent routine device interrogations.

RESULTS:

In cohort 1, 13 patients (32.5%) had one or more episodes of nonsustained VT (NSVT) on ambulatory ECG. In cohort 2, 38 patients (44.7%) had NSVT on cardiac pacemaker interrogations. During a median (interquartile range) follow-up of 3.0 (1.6 to 5.1) years, 15 (12%) patients died (20% of patients with NSVT versus 6.8% of those without NSVT; P = .03). In logistic regression analysis, NSVT was associated with a 3.4-fold higher odds of death (95% confidence interval 1.08 to 10.53; P = .04) in HFpEF.

CONCLUSIONS:

In conclusion, patients with HFpEF have a relatively high, and possibly underappreciated, burden of NSVT, which confers a higher risk of mortality. The frequent episodes of NSVT in these patients may provide insight into the mechanism of sudden cardiac death in HFpEF.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Taquicardia Ventricular / Insuficiencia Cardíaca Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Pacing Clin Electrophysiol Año: 2020 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Taquicardia Ventricular / Insuficiencia Cardíaca Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Pacing Clin Electrophysiol Año: 2020 Tipo del documento: Article